ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis (PAMOCOS)

Centre Hospitalier de Lens

Status: Completed

Conditions: Covid19

Treatments: Other: MR-Pro-ADM

Study type: Observational

Funder types: Other

Identifiers

NCT04522310

2020-05

Details and patient eligibility

About

COVID-19 is a worldwide pandemic. Around 5% of infected patients are admitted in ICU, mainly for respiratory failure. Outcome of these patients is linked to other organ failures. Optimal therapies are not defined so far. The sponsor want to assess the role of MR-ProADM as prognostic biomarker, and the impact of treatments (including supportive treatments) on MOF occurrence and outcome.

Enrollment: 183 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any adult patient admitted in the ICU with COVID-19 pneumonia

Exclusion criteria

• Pregnancy
• Legal reasons (patients under guardianship, curatorship)
• Patient's refusal